IL-13Rα2, a high-affinity decoy receptor, is minimally expressed in normal brain but overexpressed in more than 50% of GBM; abundance correlates with higher grade, invasiveness, and poor prognosis 99. This evidence concerns the gene IL13RA2 and glioblastoma.